A Bibliometric Analysis of Comorbidity of COPD and Lung Cancer: Research Status and Future Directions

References

• Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clinicians. 2021;71(3):209–249. doi:10.3322/caac.21660
   PubMed Web of Science ®Google Scholar
• Vestbo J, Hurd SS, Agustí AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013;187(4):347–365. doi:10.1164/rccm.201204-0596PP
   PubMed Web of Science ®Google Scholar
• Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (London, England). 2012;380(9859):2095–2128. doi:10.1016/S0140-6736(12)61728-0
   PubMed Web of Science ®Google Scholar
• Zhong N, Wang C, Yao W, et al. Prevalence of chronic obstructive pulmonary disease in China: a large, population-based survey. Am J Respir Crit Care Med. 2007;176(8):753–760. doi:10.1164/rccm.200612-1749OC
   PubMed Web of Science ®Google Scholar
• Global Initiative for Chronic Obstructive Lung Disease. 2020 Global strategy for prevention, diagnosis and management of COPD[EB/OL]; January 10, 2021. Available from: https://gold-copd.org/gold-report. Accessed December 19, 2023.
   Google Scholar
• Qi C, Sun, SW, Xiong, XZ . From COPD to lung cancer: mechanisms linking, diagnosis, treatment, and prognosis. Int J Chronic Obstr. 2022;17:2603–2621. doi:10.2147/COPD.S380732
   PubMed Web of Science ®Google Scholar
• Kim Y-M, Delen D. Medical informatics research trend analysis: a text mining approach. Health Inf J. 2018;24(4):432–452. doi:10.1177/1460458216678443
   PubMed Web of Science ®Google Scholar
• Zhou F, Liu Y, Liu C, et al. Knowledge landscape of tumor-associated macrophage research: a bibliometric and visual analysis. Front Immunol. 2023;14:1078705. doi:10.3389/fimmu.2023.1078705
   PubMedGoogle Scholar
• Liao J, Yu X, Chen J, et al. Knowledge mapping of autophagy in osteoarthritis from 2004 to 2022: a bibliometric analysis. Front Immunol. 2023;14:1063018. doi:10.3389/fimmu.2023.1063018
   PubMed Web of Science ®Google Scholar
• Meng L, Wen KH. An overview and trend analysis of research on the relationship between urban streets and residents’ health in China pre- and post COVID-19 pandemic. Front Public Health. 2023;11:1126656. doi:10.3389/fpubh.2023.1126656
   PubMed Web of Science ®Google Scholar
• Hirsch JE. An index to quantify an individual’s scientific research output. Proc Natl Acad Sci U S A. 2005;102(46):16569–16572. doi:10.1073/pnas.0507655102
   PubMed Web of Science ®Google Scholar
• Synnestvedt MB, Chen C, Holmes JH. Citespace II: visualization and knowledge discovery in bibliographic databases. AMIA Annu Symp Proc. 2005;2005:724–728. doi:10.1002/asi.20317
   PubMedGoogle Scholar
• Chen CM, Ibekwe-SanJuan F, Hou JH. The structure and dynamics of cocitation clusters: a multiple-perspective cocitation analysis. J Am Soc Inf SciTechnol. 2010;61(7):1386–1409. doi:10.1002/asi.21309
   Web of Science ®Google Scholar
• Qin Y, Zhang Q, Liu Y. Analysis of knowledge bases and research focuses of cerebral ischemia-reperfusion from the perspective of mapping knowledge domain. Brain Res Bull. 2020;156:15–24. doi:10.1016/j.brainresbull.2019.12.004
   PubMed Web of Science ®Google Scholar
• Freeman LC. Centrality in social networks: conceptual clarification. SocNetw. 1979;1(3):215–239. doi:10.1016/0378-8733(78)90021-728
   Google Scholar
• Brandes U. A faster algorithm for betweenness centrality. J Math Sociol. 2001;25(2):163–177. doi:10.1080/0022250X.2001.9990249
   Web of Science ®Google Scholar
• Chen CM. Science mapping: a systematic review of the literature. J of Data Inf Sci. 2017;2(2):1–40. doi:10.1515/jdis-2017-0006
   Google Scholar
• Taylor R, Najafi F, Dobson A, et al. Meta-analysis of studies of passive smoking and lung cancer: effects of study type and continent. Int J Epidemiol. 2007;36(5):1048–1059. doi:10.1093/ije/dym158
   PubMed Web of Science ®Google Scholar
• Mortaz E, Folkerts G, Nijkamp FP, et al. ATP and the pathogenesis of COPD. Eur J Pharmacol. 2010;638(1–3):1–4. doi:10.1016/j.ejphar.2010.04.019
   PubMed Web of Science ®Google Scholar
• Matakidou A, Eisen T, Houlston RS, et al. Systematic review of the relationship between family history and lung cancer risk. Br J Cancer. 2005;93(7):825–833. doi:10.1038/sj.bjc.6602769
   PubMed Web of Science ®Google Scholar
• Jin YT, Xu YC, Yang RD, et al. Familial aggregation of lung cancer in a high incidence area in China. Br J Cancer. 2005;92(7):1321–1325. doi:10.1038/sj.bjc.6602465
   PubMed Web of Science ®Google Scholar
• Raaschou-Nielsen O, Bak H, Sørensen M, et al. Air pollution from traffic and risk for lung cancer in three Danish cohorts. Cancer Epidemiol Biomarkers Prev. 2010;19(5):1284–1291. doi:10.1158/1055-9965.EPI-10-0036
   PubMed Web of Science ®Google Scholar
• De Matteis S, Consonni D, Bertazzi PA, et al. Exposure to occupational carcinogens and lung cancer risk. Evolution of epidemiological estimates of attributable fraction. Acta Biomed. 2008;79(Suppl 1):34–42.
   PubMedGoogle Scholar
• Suzuki R, Miyazaki Y, Takagi K, et al. Matrix metalloproteinases in the pathogenesis of asthma and COPD: implications for therapy. Treat Respir Med. 2004;3(1):17–27. doi:10.2165/00151829-200403010-00003
   PubMedGoogle Scholar
• Bozinovski S, Vlahos R, Hansen M, et al. Akt in the pathogenesis of COPD. Int J Chronic Obstr. 2006;1(1):31–38. doi:10.2147/copd.2006.1.1.31
   PubMedGoogle Scholar
• Reid PT, Sallenave J-M. Cytokines in the pathogenesis of chronic obstructive pulmonary disease. Curr Pharm Des. 2003;9(1):25–38. doi:10.2174/1381612033392440
   PubMed Web of Science ®Google Scholar
• Parris BA, O’Farrell HE, Fong KM, et al. Chronic obstructive pulmonary disease (COPD) and lung cancer: common pathways for pathogenesis. J Thoracic Dis. 2019;11(Suppl 17):S2155–S2172. doi:10.21037/jtd.2019.10.54
   PubMedGoogle Scholar
• Houghton AM. Mechanistic links between COPD and lung cancer. Nat Rev Cancer. 2013;13(4):233–245. PMID: 23467302. doi:10.1038/nrc3477
   PubMed Web of Science ®Google Scholar
• Pastor MD, Nogal A, Molina-Pinelo S, et al. Identification of proteomic signatures associated with lung cancer and COPD. J Proteom. 2013;89:227–237. doi:10.1016/j.jprot.2013.04.037
   PubMed Web of Science ®Google Scholar
• Binkley MS, King MT, Shrager JB, et al. Pulmonary function after lung tumor stereotactic ablative radiotherapy depends on regional ventilation within irradiated lung. Radiother Oncol. 2017;123(2):270–275. PMID: 28460826. doi:10.1016/j.radonc.2017.03.021
   PubMed Web of Science ®Google Scholar
• Young RP, Hopkins RJ, Gamble GD, et al. Genetic evidence linking lung cancer and COPD: a new perspective. Appl Clin Gen. 2011;4:99–111. doi:10.2147/TACG.S20083
   Google Scholar
• Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108. PMID: 25651787. doi:10.3322/caac.21262
   PubMed Web of Science ®Google Scholar
• Sinden NJ, Baker MJ, Smith DJ, Kreft JU, Dafforn TR, Stockley RA. α-1-antitrypsin variants and the proteinase/antiproteinase imbalance in chronic obstructive pulmonary disease. Am J Physiol Lung Cell Mol Physiol. 2015;308(2):L179–90. PMID: 25416382; PMCID: PMC4338942. doi:10.1152/ajplung.00179.2014
   PubMed Web of Science ®Google Scholar
• Hogg JC, Chu F, Utokaparch S, et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med. 2004;350(26):2645–2653. PMID: 15215480. doi:10.1056/NEJMoa032158
   PubMed Web of Science ®Google Scholar
• Caramori G, Casolari P, Cavallesco GN, Giuffrè S, Adcock I, Papi A. Mechanisms involved in lung cancer development in COPD. Int J Biochem Cell Biol. 2011;43(7):1030–1044. PMID: 20951226. doi:10.1016/j.biocel.2010.08.022
   PubMed Web of Science ®Google Scholar
• Hung RJ, McKay JD, Gaborieau V, et al. A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature. 2008;452(7187):633–637. PMID: 18385738. doi:10.1038/nature06885
   PubMed Web of Science ®Google Scholar
• Pillai SG, Ge D, Zhu G, et al.; ICGN Investigators. A genome-wide association study in chronic obstructive pulmonary disease (COPD): identification of two major susceptibility loci. PLoS Genet. 2009;5(3):e1000421. PMID: 19300482; PMCID: PMC2650282. doi:10.1371/journal.pgen.1000421
   PubMed Web of Science ®Google Scholar
• Amos CI, Wu X, Broderick P, et al. Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1. Nat Genet. 2008;40(5):616–622. PMID: 18385676; PMCID: PMC2713680. doi:10.1038/ng.109
   PubMed Web of Science ®Google Scholar
• Park JY, Chen L, Elahi A, Lazarus P, Tockman MS. Genetic analysis of microsomal epoxide hydrolase gene and its association with lung cancer risk. Eur J Cancer Prev. 2005;14(3):223–230. PMID: 15901990; PMCID: PMC3715303. doi:10.1097/00008469-200506000-00005
   PubMed Web of Science ®Google Scholar
• Stemmler S, Arinir U, Klein W, et al. Association of interleukin-8 receptor alpha polymorphisms with chronic obstructive pulmonary disease and asthma. Genes Immun. 2005;6(3):225–230. PMID: 15772681. doi:10.1038/sj.gene.6364181
   PubMed Web of Science ®Google Scholar
• Adcock IM, Caramori G, Barnes PJ. Chronic obstructive pulmonary disease and lung cancer: new molecular insights. Respiration. 2011;81(4):265–284. PMID: 21430413. doi:10.1159/000324601
   PubMed Web of Science ®Google Scholar
• Pierrou S, Broberg P, O’Donnell RA, et al. Expression of genes involved in oxidative stress responses in airway epithelial cells of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2007;175(6):577–586. PMID: 17158281. doi:10.1164/rccm.200607-931OC
   PubMed Web of Science ®Google Scholar
• Spira A, Beane JE, Shah V, et al. Airway epithelial gene expression in the diagnostic evaluation of smokers with suspect lung cancer. Nat Med. 2007;13(3):361–366. PMID: 17334370. doi:10.1038/nm1556
   PubMed Web of Science ®Google Scholar
• Rajendrasozhan S, Yang SR, Kinnula VL, Rahman I. SIRT1, an antiinflammatory and antiaging protein, is decreased in lungs of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2008;177(8):861–870. PMID: 18174544; PMCID: PMC2292827. doi:10.1164/rccm.200708-1269OC
   PubMed Web of Science ®Google Scholar
• Howard P, Knight C, Boler A, Baker C. Cost-utility analysis of varenicline versus existing smoking cessation strategies using the BENESCO Simulation model: application to a population of US adult smokers. Pharmacoeconomics. 2008;26(6):497–511. PMID: 18489200. doi:10.2165/00019053-200826060-00004
   PubMed Web of Science ®Google Scholar
• Gonzales D, Rennard SI, Nides M, et al.; Varenicline Phase 3 Study Group. Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial. JAMA. 2006;296(1):47–55. PMID: 16820546. doi:10.1001/jama.296.1.47
   PubMed Web of Science ®Google Scholar
• Stead LF, Perera R, Bullen C, Mant D, Lancaster T. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev. 2008;1:CD000146. Update in: Cochrane Database Syst Rev. 2012;11:CD000146. PMID: 18253970. doi:10.1002/14651858.CD000146.pub3
   PubMed Web of Science ®Google Scholar
• Yang IA, Relan V, Wright CM, et al. Common pathogenic mechanisms and pathways in the development of COPD and lung cancer. Expert Opin Ther Targets. 2011;15(4):439–456. PMID: 21284573. doi:10.1517/14728222.2011.555400
   PubMed Web of Science ®Google Scholar
• Durham AL, Adcock IM. The relationship between COPD and lung cancer. Lung Cancer. 2015;90(2):121–127. PMID: 26363803; PMCID: PMC4718929. doi:10.1016/j.lungcan.2015.08.017
   PubMed Web of Science ®Google Scholar
• Wilson DO, Weissfeld JL, Balkan A, et al. Association of radiographic emphysema and airflow obstruction with lung cancer. Am J Respir Crit Care Med. 2008;178(7):738–744. PMID: 18565949; PMCID: PMC2556456. doi:10.1164/rccm.200803-435OC
   PubMed Web of Science ®Google Scholar
• Young RP, Hopkins RJ, Christmas T, Black PN, Metcalf P, Gamble GD. COPD prevalence is increased in lung cancer, independent of age, sex and smoking history. Eur Respir J. 2009;34(2):380–386. PMID: 19196816. doi:10.1183/09031936.00144208
   PubMed Web of Science ®Google Scholar
• Turner MC, Chen Y, Krewski D, Calle EE, Thun MJ. Chronic obstructive pulmonary disease is associated with lung cancer mortality in a prospective study of never smokers. Am J Respir Crit Care Med. 2007;176(3):285–290. PMID: 17478615. doi:10.1164/rccm.200612-1792OC
   PubMed Web of Science ®Google Scholar
• Perrotta F, D’Agnano V, Scialò F, et al. Evolving concepts in COPD and lung cancer: a narrative review. Minerva Med. 2022;113(3):436–448. PMID: 35156786. doi:10.23736/S0026-4806.22.07962-9
   PubMed Web of Science ®Google Scholar
• Mark NM, Kargl J, Busch SE, et al. Chronic obstructive pulmonary disease alters immune cell composition and immune checkpoint inhibitor efficacy in non-small cell lung cancer. Am J Respir Crit Care Med. 2018;197(3):325–336. PMID: 28934595; PMCID: PMC5803651. doi:10.1164/rccm.201704-0795OC
   PubMed Web of Science ®Google Scholar
• Trappe A, Donnelly SC, McNally P, Coppinger JA. Role of extracellular vesicles in chronic lung disease. Thorax. 2021;76(10):1047–1056. PMID: 33712504; PMCID: PMC8461402. doi:10.1136/thoraxjnl-2020-216370
   PubMed Web of Science ®Google Scholar
• Eapen MS, Hansbro PM, Larsson-Callerfelt AK, et al. Chronic obstructive pulmonary disease and lung cancer: underlying pathophysiology and new therapeutic modalities. Drugs. 2018;78(16):1717–1740. PMID: 30392114. doi:10.1007/s40265-018-1001-8
   PubMed Web of Science ®Google Scholar
• Burnett RT, Pope CA 3rd, Ezzati M, et al. An integrated risk function for estimating the global burden of disease attributable to ambient fine particulate matter exposure. Environ Health Perspect. 2014;122(4):397–403. Erratum in: Environ Health Perspect. 2014 Sep;122(9):A235. PMID: 24518036; PMCID: PMC3984213. doi:10.1289/ehp.1307049
   PubMed Web of Science ®Google Scholar
• Cohen AJ, Brauer M, Burnett R, et al. Estimates and 25-year trends of the global burden of disease attributable to ambient air pollution: an analysis of data from the Global Burden of Diseases Study 2015. Lancet. 2017;389(10082):1907–1918. Erratum in: Lancet. 2017 Jun 17;389(10087):e15. Erratum in: Lancet. 2018 Apr 21;391(10130):1576. PMID: 28408086;PMCID: PMC5439030. doi:10.1016/S0140-6736(17)30505-6
   PubMed Web of Science ®Google Scholar
• Maji KJ, Dikshit AK, Arora M, Deshpande A. Estimating premature mortality attributable to PM2.5 exposure and benefit of air pollution control policies in China for 2020. Sci Total Environ. 2018;612:683–693. PMID: 28866396. doi:10.1016/j.scitotenv.2017.08.254
   PubMed Web of Science ®Google Scholar
• Huang JY, Jian ZH, Ndi Nfor O, et al. The impact of coexisting asthma, chronic obstructive pulmonary disease and tuberculosis on survival in patients with lung squamous cell carcinoma. PLoS One. 2015;10(7):e0133367. PMID: 26196516; PMCID: PMC4510446. doi:10.1371/journal.pone.0133367
   PubMed Web of Science ®Google Scholar
• Brenner DR, McLaughlin JR, Hung RJ. Previous lung diseases and lung cancer risk: a systematic review and meta-analysis. PLoS One. 2011;6(3):e17479. PMID: 21483846; PMCID: PMC3069026. doi:10.1371/journal.pone.0017479
   PubMed Web of Science ®Google Scholar
• Triplette M, Crothers K, Attia EF. Non-infectious pulmonary diseases and HIV. Curr HIV/AIDS Rep. 2016;13(3):140–148. PMID: 27121734. doi:10.1007/s11904-016-0313-0
   PubMed Web of Science ®Google Scholar
• Lambert AA, Kirk GD, Astemborski J, Mehta SH, Wise RA, Drummond MB. HIV infection is associated with increased risk for acute exacerbation of COPD. J Acquir Immune Defic Syndr. 2015;69(1):68–74. PMID: 25942460; PMCID: PMC4422097. doi:10.1097/QAI.0000000000000552
   PubMed Web of Science ®Google Scholar
• Gingo MR, Balasubramani GK, Kingsley L, et al. The impact of HAART on the respiratory complications of HIV infection: longitudinal trends in the MACS and WIHS cohorts. PLoS One. 2013;8(3):e58812. PMID: 23554932; PMCID: PMC3595204. doi:10.1371/journal.pone.0058812
   PubMed Web of Science ®Google Scholar
• Higginson IJ, Bausewein C, Reilly CC, et al. An integrated palliative and respiratory care service for patients with advanced disease and refractory breathlessness: a randomized controlled trial. Lancet Respir Med. 2014;2(12):979–987. PMID: 25465642. doi:10.1016/S2213-2600(14)70226-7
   PubMed Web of Science ®Google Scholar
• Curtis JR. Palliative and end-of-life care for patients with severe COPD. Eur Respir J. 2008;32(3):796–803. PMID: 17989116. doi:10.1183/09031936.00126107
   PubMed Web of Science ®Google Scholar
• Divo M, Cote C, de Torres JP, et al.; BODE Collaborative Group. Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012;186(2):155–161. PMID: 22561964. doi:10.1164/rccm.201201-0034OC
   PubMed Web of Science ®Google Scholar
• Barnes PJ, Celli BR. Systemic manifestations and comorbidities of COPD. Eur Respir J. 2009;33(5):1165–1185. PMID: 19407051. doi:10.1183/09031936.00128008
   PubMed Web of Science ®Google Scholar
• Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3(11):e442. PMID: 17132052; PMCID: PMC1664601. doi:10.1371/journal.pmed.0030442
   PubMed Web of Science ®Google Scholar
• Jemal A, Ward E, Hao Y, Thun M. Trends in the leading causes of death in the United States, 1970–2002. JAMA. 2005;294(10):1255–1259. PMID: 16160134. doi:10.1001/jama.294.10.1255
   PubMed Web of Science ®Google Scholar
• Kauczor HU, Bonomo L, Gaga M, et al. European Society of Radiology (ESR); European Respiratory Society (ERS). ESR/ERS white paper on lung cancer screening. Eur Radiol. 2015;25(9):2519–2531. PMID: 25929939; PMCID: PMC4529446. doi:10.1007/s00330-015-3697-0
   PubMed Web of Science ®Google Scholar
• Moyer VA; U.S. Preventive Services Task Force. Screening for lung cancer: u.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2014;160(5):330–338. PMID: 24378917. doi:10.7326/M13-2771
   PubMed Web of Science ®Google Scholar
• Rahmanian SD, Diaz PT, Wewers ME. Tobacco use and cessation among women: research and treatment-related issues. J Womens Health (Larchmt). 2011;20(3):349–357. PMID: 21375414; PMCID: PMC3058892. doi:10.1089/jwh.2010.2173
   PubMed Web of Science ®Google Scholar
• Gan WQ, Man SF, Postma DS, Camp P, Sin DD. Female smokers beyond the perimenopausal period are at increased risk of chronic obstructive pulmonary disease: a systematic review and meta-analysis. Respir Res. 2006;7(1):52. PMID: 16571126; PMCID: PMC1435894. doi:10.1186/1465-9921-7-52
   PubMedGoogle Scholar
• Di Marco F, Verga M, Reggente M, et al. Anxiety and depression in COPD patients: the roles of gender and disease severity. Respir Med. 2006;100(10):1767–1774. PMID: 16531031. doi:10.1016/j.rmed.2006.01.026
   PubMed Web of Science ®Google Scholar
• Shin SH, Shin S, Im Y, et al. Effect of perioperative bronchodilator therapy on postoperative pulmonary function among lung cancer patients with COPD. Sci Rep. 2021;11:8359. doi:10.1038/s41598-021-86791-1
   PubMed Web of Science ®Google Scholar
• Wang F, Xie XH, Lin XQ, et al. Exploration of the treatment model for patients with advanced non-small cell lung cancer complicated with chronic obstructive pulmonary disease based on real-world data. Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:450–454.
   PubMedGoogle Scholar
• Ajimizu H, Ozasa H, Sato S, et al. Survival impact of treatment for chronic obstructive pulmonary disease in patients with advanced non-small-cell lung cancer. Sci Rep. 2021;11:23677. doi:10.1038/s41598-021-03139-5
   PubMed Web of Science ®Google Scholar
• Mouronte-Roibás C, Leiro-Fernández V, Fernández-Villar A, Botana-Rial M, Ramos-Hernández C, Ruano-Ravina A. COPD, emphysema and the onset of lung cancer. A systematic review. Cancer Lett. 2016;382(2):240–244. doi:10.1016/j.canlet.2016.09.002
   PubMed Web of Science ®Google Scholar
• Zhang J, Zhou JB, Lin XF, Wang Q, Bai CX, Hong QY. Prevalence of undiagnosed and undertreated chronic obstructive pulmonary disease in lung cancer population. Respirology. 2013;18(2):297–302. doi:10.1111/j.1440-1843.2012.02282.x
   PubMed Web of Science ®Google Scholar
• Lin M, Huang Z, Chen Y, et al. Lung cancer patients with chronic obstructive pulmonary disease benefit from anti-PD-1/PD-L1 therapy. Front Immunol. 2022;13:1038715. doi:10.3389/fimmu.2022.1038715
   PubMedGoogle Scholar
• Nucera F, Mumby S, Paudel KR, et al. Role of oxidative stress in the pathogenesis of COPD. Minerva Med. 2022;113(3):370–404. doi:10.23736/S0026-4806.22.07972-1
   PubMed Web of Science ®Google Scholar
• Caramori G, Ruggeri P, Mumby S, et al. Molecular links between COPD and lung cancer: new targets for drug discovery? Expert Opin Ther Targets. 2019;23(6):539–553. doi:10.1080/14728222.2019.1615884
   PubMed Web of Science ®Google Scholar